Notice NOT-HD-23-008 from the NIH Guide for Grants and Contracts

Notice NOT-DC-23-006 from the NIH Guide for Grants and Contracts

Notice NOT-CA-23-055 from the NIH Guide for Grants and Contracts

Notice NOT-CA-23-054 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-NS-23-022 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to invite exploratory and innovative research applications focused on theneurological and neuropsychiatric manifestationsof COVID-19 (neuro-COVID) andPost-Acute Sequelae of SARS-CoV-2 Infection (neuro-PASC) and on the effect of COVID-19 on pre-infection neurologic conditions. Applications investigating the pathophysiology and mechanisms of neuro-COVID and neuro-PASC and neurologically-focused human subjects research, as well as those proposing studies of scientifically compelling pathways to prevent the development of neuro-PASC or to accelerate the development of effective treatments forPASC-related neurological complications are of particular interest for this NOFO.

Funding Opportunity RFA-NS-23-021 from the NIH Guide for Grants and Contracts. The purpose of thisNotice of Funding Opportunity (NOFO)is to invite applicationsfocused on theneurological and neuropsychiatric manifestationsof COVID-19 (neuro-COVID) andPost-Acute Sequelae of SARS-CoV-2 Infection (neuro-PASC) and on the effect of COVID-19 on pre-infection neurologic conditions. Applications investigating the pathophysiology and mechanisms of neuro-COVID and neuro-PASC and neurologically-focused human subjects research, as well as those proposing studies of scientifically compelling pathways to prevent the development of neuro-PASC or to accelerate the development of effective treatments forPASC-related neurological complications are of particular interest for this NOFO.

Funding Opportunity RFA-RM-23-005 from the NIH Guide for Grants and Contracts. The NIH Directors New Innovator Award Program supports early stage investigators of exceptional creativity who propose highly innovative research projects with the potential to produce a major impact on broad, important problems relevant to the mission of NIH. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. Individuals from diverse backgrounds and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply to this Funding Opportunity Announcement. In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. The NIH Director's New Innovator Award Program complements ongoing efforts by NIH and its Institutes and Centers to fund early stage investigators through R01 grants, which continue to be the major sources of NIH support for early stage investigators. The NIH Directors New Innovator Award Program is a component of the High-Risk, High-Reward Research Program of the NIH Common Fund.

Notice NOT-AI-23-040 from the NIH Guide for Grants and Contracts

Notice NOT-AT-24-003 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-RM-23-006 from the NIH Guide for Grants and Contracts. The NIH Directors Transformative Research Award Program supports individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original, and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the nations research workforce. Individuals from diverse backgrounds, including those from underrepresented groups (see, Notice of NIH's Interest in Diversity, NOT-OD-20-031) are strongly encouraged to apply to this Funding Opportunity Announcement. In addition, applications are welcome from the full spectrum of eligible institutions in all geographic locations and in all topic areas relevant to the broad mission of NIH, including, but not limited to, behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. No preliminary data are required. Projects must clearly demonstrate, based on the strength of the logic, a compelling potential to produce a major impact in a broad area of relevance to the NIH. The NIH Directors Transformative Research Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund. Towards the objective of funding the best possible science, the Office of Strategic Coordination and the Center for Scientific Review are piloting a process for initial peer review of applications received in response to this FOA in which the identity of the investigators and institutions are withheld until the last phase of review. Instructions for anonymizing components of the application are given in Section IV and must be carefully followed. A description of the review process is given in Section V.

Notice NOT-AT-24-001 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-105 from the NIH Guide for Grants and Contracts

Notice NOT-DC-23-005 from the NIH Guide for Grants and Contracts

Notice NOT-NS-23-078 from the NIH Guide for Grants and Contracts

Notice NOT-HG-23-023 from the NIH Guide for Grants and Contracts

Notice NOT-RM-23-006 from the NIH Guide for Grants and Contracts

Notice NOT-MD-23-010 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-RM-23-002 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to invite applications for an Integration and Coordination Center (ICC) for the Common Fund Data Ecosystem (CFDE) that will help to build internal cohesion within the program. Award(s) made through this FOA will support CFDE by integrating relevant Common Fund (CF) programs within CFDE, coordinating across other CFDE centers, helping CF programs develop data sustainability plans, and ensuring continuous improvement through an annual evaluation program. The awardee(s) will work collaboratively with each other and other participating components of the CFDE to integrate and coordinate activities across the ecosystem. The end products of CFDE will be a thriving ecosystem that enables the research community to reuse CF data and resources for discoveries and new purposes.

Funding Opportunity RFA-AI-23-018 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages research focused on defining the molecular mechanisms by which HIV proteins and/or nucleic acids induce inflammation, immune activation and HIV persistence during viral suppression as well as on developing novel therapeutic strategies to mitigate or eliminate the effects of continued HIV expression.

Notice NOT-AI-23-035 from the NIH Guide for Grants and Contracts